LIPLASOME PHARMA ApS — Credit Rating and Financial Key Figures

CVR number: 29428514
Tabletvej 1, 7100 Vejle
tel: 49288888

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit- 133.00108.002 202.00-29.00-53.00
Total depreciation-51.00
EBIT- 184.00108.002 202.00-29.00-53.00
Other financial income13.009.004.004.008.00
Other financial expenses-29.00-19.00-10.00-1.00-1.00
Pre-tax profit- 200.0098.002 196.00-26.00-46.00
Income taxes44.006.0010.00
Net earnings- 156.0098.002 196.00-20.00-36.00

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors1 221.0039.0062.00252.00
Current amounts owed by group member comp.2 000.002 000.00
Current other receivables2.003.00
Current deferred tax assets44.0044.006.0010.00
Short term receivables total1 265.0085.0062.002 258.002 013.00
Cash and bank deposits259.00102.002 321.00105.00317.00
Cash and cash equivalents259.00102.002 321.00105.00317.00
Balance sheet total (assets)1 524.00187.002 383.002 363.002 330.00

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital46 201.0092.0092.0092.0092.00
Retained earnings-45 968.00-15.0083.002 279.002 259.00
Profit of the financial year- 156.0098.002 196.00-20.00-36.00
Shareholders equity total77.00175.002 371.002 351.002 315.00
Non-current liabilities total
Current trade creditors294.0012.0011.0012.0015.00
Current owed to group member1 128.00
Other non-interest bearing current liabilities25.001.00
Current liabilities total1 447.0012.0012.0012.0015.00
Balance sheet total (liabilities)1 524.00187.002 383.002 363.002 330.00
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.